Assessment of Glycemic Control Protocol (STAR) Through Compliance Analysis Amongst Malaysian ICU Patients.
compliance
diabetes
glycemic control
model-based control
stochastic targeted prediction
Journal
Medical devices (Auckland, N.Z.)
ISSN: 1179-1470
Titre abrégé: Med Devices (Auckl)
Pays: New Zealand
ID NLM: 101566041
Informations de publication
Date de publication:
2020
2020
Historique:
received:
20
09
2019
accepted:
15
01
2020
entrez:
2
7
2020
pubmed:
2
7
2020
medline:
2
7
2020
Statut:
epublish
Résumé
This paper presents an assessment of an automated and personalized stochastic targeted (STAR) glycemic control protocol compliance in Malaysian intensive care unit (ICU) patients to ensure an optimized usage. STAR proposes 1-3 hours treatment based on individual insulin sensitivity variation and history of blood glucose, insulin, and nutrition. A total of 136 patients recorded data from STAR pilot trial in Malaysia (2017-quarter of 2019*) were used in the study to identify the gap between chosen administered insulin and nutrition intervention as recommended by STAR, and the real intervention performed. The results show the percentage of insulin compliance increased from 2017 to first quarter of 2019* and fluctuated in feed administrations. Overall compliance amounted to 98.8% and 97.7% for administered insulin and feed, respectively. There was higher average of 17 blood glucose measurements per day than in other centres that have been using STAR, but longer intervals were selected when recommended. Control safety and performance were similar for all periods showing no obvious correlation to compliance. The results indicate that STAR, an automated model-based protocol is positively accepted among the Malaysian ICU clinicians to automate glycemic control and the usage can be extended to other hospitals already. Performance could be improved with several propositions.
Identifiants
pubmed: 32607009
doi: 10.2147/MDER.S231856
pii: 231856
pmc: PMC7282801
doi:
Types de publication
Journal Article
Langues
eng
Pagination
139-149Informations de copyright
© 2020 Abdul Razak et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
J Diabetes Sci Technol. 2012 Jan 01;6(1):37-47
pubmed: 22401321
J Diabetes Sci Technol. 2018 Jan;12(1):7-19
pubmed: 29103302
BMC Pediatr. 2012 Aug 07;12:117
pubmed: 22871230
Crit Care. 2017 Jun 24;21(1):152
pubmed: 28645302
Ann Intensive Care. 2016 Dec;6(1):24
pubmed: 27025951
N Engl J Med. 2001 Nov 8;345(19):1359-67
pubmed: 11794168
J Diabetes Sci Technol. 2016 Nov 1;10(6):1372-1381
pubmed: 27170632
Comput Methods Programs Biomed. 2012 Nov;108(2):844-59
pubmed: 21885150
World J Diabetes. 2017 Mar 15;8(3):89-96
pubmed: 28344751
Int J Gen Med. 2012;5:23-6
pubmed: 22259258
J Diabetes Sci Technol. 2012 Jan 01;6(1):102-15
pubmed: 22401328
J Crit Care. 2014 Jun;29(3):374-9
pubmed: 24679489
J Diabetes Sci Technol. 2012 Sep 01;6(5):1030-7
pubmed: 23063028
Comput Methods Programs Biomed. 2008 Feb;89(2):141-52
pubmed: 17544541
Crit Care. 2018 Aug 2;22(1):182
pubmed: 30071851
N Engl J Med. 2008 Jan 10;358(2):125-39
pubmed: 18184958
Comput Methods Programs Biomed. 2011 May;102(2):192-205
pubmed: 21288592
CMAJ. 2009 Apr 14;180(8):799-800
pubmed: 19318386
Crit Care. 2015 Apr 20;19:179
pubmed: 25927986
Arch Dis Child Fetal Neonatal Ed. 2019 Mar;104(2):F205-F211
pubmed: 29930148
Chest. 2019 Nov;156(5):878-886
pubmed: 31201784
Crit Care. 2016 Sep 27;20(1):301
pubmed: 27677709
Biomed Eng Online. 2018 Feb 20;17(1):24
pubmed: 29463246
Blood Purif. 2008;26(1):73-6
pubmed: 18182801
BMC Anesthesiol. 2016 Jan 22;16:8
pubmed: 26801983
Med Devices (Auckl). 2019 May 31;12:215-226
pubmed: 31239792
J Diabetes Sci Technol. 2012 Jan 01;6(1):125-34
pubmed: 22401330
Endocr Pract. 2017 Mar;23(3):331-341
pubmed: 27967226
Biomed Eng Online. 2012 Aug 23;11:58
pubmed: 22917085
Ann Intensive Care. 2018 Jan 10;8(1):4
pubmed: 29330610
Comput Methods Programs Biomed. 2006 Jun;82(3):238-47
pubmed: 16647157
Am J Crit Care. 2006 Jul;15(4):370-7
pubmed: 16823014
J Diabetes Sci Technol. 2019 Jul;13(4):682-690
pubmed: 30638048
IEEE Trans Biomed Eng. 2018 Jul;65(7):1543-1553
pubmed: 28358672
J Diabetes Sci Technol. 2008 May;2(3):409-16
pubmed: 19885205
Crit Care. 2010;14(4):R154
pubmed: 20704712
Crit Care. 2008;12(2):R49
pubmed: 18412978
Comput Methods Programs Biomed. 2018 Nov;166:9-18
pubmed: 30415721
N Engl J Med. 2012 Sep 20;367(12):1108-18
pubmed: 22992074
Mayo Clin Proc. 2004 Aug;79(8):992-1000
pubmed: 15301325
J Crit Care. 2015 Jun;30(3):455-9
pubmed: 25682344
Pharmacotherapy. 2006 Feb;26(2):214-28
pubmed: 16466326
IEEE Trans Biomed Eng. 2010 Mar;57(3):509-18
pubmed: 19884072
Lancet. 2009 May 23;373(9677):1798-807
pubmed: 19465235
Crit Care Med. 2008 Nov;36(11):3008-13
pubmed: 18824908
J Diabetes Sci Technol. 2012 Jan 01;6(1):135-43
pubmed: 22401331